• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RENEGADE HI-FLO; CATHETER, CONTINUOUS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RENEGADE HI-FLO; CATHETER, CONTINUOUS FLUSH Back to Search Results
Model Number 29420
Medical Device Problem Code Difficult to Advance (2920)
Health Effect - Clinical Code Vasoconstriction (2126)
Date of Event 07/10/2023
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that vasospasm occurred.The target lesion was in the mildly calcified liver vessel.The blood vessel had two opposite curvatures very close to each other, especially the first one which was nearly 90 degrees.A 135/10 renegade hi flo was selected for use.After a liver procedure, the patient underwent hepatic arteriography and proper hepatic artery chemoembolization due to interventional therapy for malignant tumor and liver malignant tumor.This device was needed for hepatic arterial infusion chemotherapy.The charge nurse took out the microcatheter with complete outer package, and after the physician successfully selected the hepatic artery branch according to the normal operation steps, the operator tried to follow it up with the microcatheter.The microcatheter could not be advanced and failed many times.After the first curvature was crossed, it was difficult to immediately cross the next one at an opposite angle, and the catheter tip was easy to stick against the blood vessel wall.It was found that the patient had vascular spasm which made it impossible to continue the hepatic artery embolization.After use, the blood vessel got wrinkled and spasmodic.The hepatic artery embolization was stopped immediately, and the perfusion chemotherapy was continued.However, the chemotherapy drugs injected into the patient during the infusion chemotherapy were reduced, which might affect the chemotherapy effect.The device was removed through the angiographic catheter and the procedure was completed with a different device.The patient has recovered well and the skin at the puncture site has healed well without redness, swelling and pressing pain.
 
Additional Manufacturer Narrative
F10.Removed inadequate/inappropriate treatment or diagnostic exposure code.
 
Event or Problem Description
It was reported that vasospasm occurred.The target lesion was in the mildly calcified liver vessel.The blood vessel had two opposite curvatures very close to each other, especially the first one which was nearly 90 degrees.A 135/10 renegade hi flo was selected for use.After a liver procedure, the patient underwent hepatic arteriography and proper hepatic artery chemoembolization due to interventional therapy for malignant tumor and liver malignant tumor.This device was needed for hepatic arterial infusion chemotherapy.The charge nurse took out the microcatheter with complete outer package, and after the physician successfully selected the hepatic artery branch according to the normal operation steps, the operator tried to follow it up with the microcatheter.The microcatheter could not be advanced and failed many times.After the first curvature was crossed, it was difficult to immediately cross the next one at an opposite angle, and the catheter tip was easy to stick against the blood vessel wall.It was found that the patient had vascular spasm which made it impossible to continue the hepatic artery embolization.After use, the blood vessel got wrinkled and spasmodic.The hepatic artery embolization was stopped immediately, and the perfusion chemotherapy was continued.However, the chemotherapy drugs injected into the patient during the infusion chemotherapy were reduced, which might affect the chemotherapy effect.The device was removed through the angiographic catheter and the procedure was completed with a different device.The patient has recovered well and the skin at the puncture site has healed well without redness, swelling and pressing pain.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RENEGADE HI-FLO
Common Device Name
CATHETER, CONTINUOUS FLUSH
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORK LIMITED
model farm road
cork T12 Y K88
EI   T12 YK88
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17747123
Report Number2124215-2023-47745
Device Sequence Number14772745
Product Code KRA
UDI-Device Identifier08714729280637
UDI-Public08714729280637
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K140329
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/16/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/30/2025
Device Model Number29420
Device Catalogue Number29420
Device Lot Number0029505383
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/30/2023
Supplement Date Received by Manufacturer09/21/2023
Initial Report FDA Received Date09/14/2023
Supplement Report FDA Received Date10/16/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured05/31/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
GUIDE CATHETER: 5F; GUIDE CATHETER: 5F
Outcome Attributed to Adverse Event Other;
Patient Age51 YR
Patient SexMale
-
-